Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histopathological Incidence of Amyloidosis in High-Risk Patients Undergoing Cardiac Device Implantation

NCT06186167 is registered in ClinicalTrials.gov with Midwest Heart & Vascular Specialists as lead sponsor.

NCT NCT06186167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histopathological Incidence of Amyloidosis in High-Risk Patients Undergoing Cardiac Device Implantation
Lead sponsor
Midwest Heart & Vascular Specialists
Phase
Observational
Overall status
Unknown status
Start date
January 29, 2024
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, amyloid, amyloidosis cardiac, attr amyloidosis wild type, cardiac amyloidosis, infiltrative cardiomyopathy, amyloid, systemic amyloidosis